Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
Claude Maraoui
|
| gptkbp:focusesOn |
dermatology
|
| gptkbp:foundedYear |
2014
|
| gptkbp:headquartersLocation |
gptkb:Scottsdale,_Arizona,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Journey Medical Corporation
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
approximately 50 (as of 2023)
|
| gptkbp:parentCompany |
gptkb:Fortress_Biotech
|
| gptkbp:product |
gptkb:Accutane
gptkb:Qbrexza Exelderm Targadox |
| gptkbp:specializesIn |
prescription dermatology products
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:DERM
|
| gptkbp:website |
https://www.journeymedicalcorp.com/
|
| gptkbp:bfsParent |
gptkb:Fortress_Biotech
|
| gptkbp:bfsLayer |
7
|